Very high-power short-duration ablation for treatment of premature ventricular contractions: Truth or Dare?

Sevasti-Maria Chaldoupi¹, Justin Luermans^{1

2}, Dominik Linz^{1

2

3

4}

Affiliations

¹ Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
² Department of Cardiology, Radboud University Medical Center and Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
³ Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
⁴ Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Editorial

Sevasti-Maria Chaldoupi et al. Int J Cardiol Heart Vasc. 2022.

. 2022 May 13:40:101053.

doi: 10.1016/j.ijcha.2022.101053. eCollection 2022 Jun.

Sevasti-Maria Chaldoupi¹, Justin Luermans^{1

2}, Dominik Linz^{1

2

3

4}

¹ Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, the Netherlands.
² Department of Cardiology, Radboud University Medical Center and Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
³ Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.
⁴ Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

No abstract available

References

1. Chaldoupi S.-M., Luermans J., Vernooy K., Linz D. High-power short-duration ablation: The new standard for pulmonary vein isolation? Int. J. Cardiol. Heart Vasc. 2021;36:100865. - PMC - PubMed
1. Winkle R.A. HPSD ablation for AF high-power short-duration RF ablation for atrial fibrillation: A review. J. Cardiovasc. Electrophysiol. 2021;32(10):2813–2823. - PubMed
1. Winkle R.A., Mohanty S., Patrawala R.A., Mead R.H., Kong M.H., Engel G., Salcedo J., Trivedi C.G., Gianni C., Jais P., Natale A., Day J.D. Low complication rates using high power (45–50 W) for short duration for atrial fibrillation ablations. Heart Rhythm. 2019;16(2):165–169. - PubMed
1. Reddy V.Y., Grimaldi M., De Potter T., Vijgen J.M., Bulava A., Duytschaever M.F., Martinek M., Natale A., Knecht S., Neuzil P., Pürerfellner H. Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial. JACC Clin. Electrophysiol. 2019;5:778–786. - PubMed
1. Halbfass P., Wielandts J.Y., Knecht S., Polain L.e., de Waroux J.B., Tavernier R., De Wilde V., Sonne K., Nentwich K., Ene E., Berkovitz A., Mueller J., Lehmkuhl L., Reichart A., Lüsebrink U., Duytschaever M., Deneke T. Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury. Europace. 2022;24:400–405. - PubMed